Using a systems biology approach, we identified a novel mechanism by which the knockdown of ANRIL and/or UFC1 can modulate the miR-34a/Myc pathway at the G1/S checkpoint in NSCLC. The gene discussed is CDKN2B-AS1; the disease is non-small cell lung carcinoma.